Risks and benefits of phase 1 oncology trials in the era of personalized medicine

被引：1
|
作者：
Chakiba, C. [1 ]
Grellety, T. [1 ]
Cousin, S. [1 ]
Italiano, A. [1 ]
机构：
[1] Inst Bergonie, Med Oncol, Bordeaux, France
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw387.9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1372P
引用
收藏
页数：1
相关论文
共 50 条
  • [21] The changing face of clinical trials in the personalized medicine and immuno-oncology era: report from the international congress on clinical trials in Oncology & Hemato-Oncology (ICTO 2017)
    Golan, Talia
    Milella, Michele
    Ackerstein, Aliza
    Berger, Ranaan
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2017, 36
  • [22] The changing face of clinical trials in the personalized medicine and immuno-oncology era: report from the international congress on clinical trials in Oncology & Hemato-Oncology (ICTO 2017)
    Talia Golan
    Michele Milella
    Aliza Ackerstein
    Ranaan Berger
    Journal of Experimental & Clinical Cancer Research, 36
  • [23] Trends in the risks and benefits to patients with cancer in phase 1 clinical trials
    Ross, S
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (07): : 795 - 795
  • [24] A Review of Practice-Changing Therapies in Oncology in the Era of Personalized Medicine
    Capella, Mariana Pilon
    Esfahani, Khashayar
    CURRENT ONCOLOGY, 2024, 31 (04) : 1913 - 1919
  • [25] Personalized medicine in oncology
    Loersch, Alisa Martina
    Jung, Johannes
    Lange, Sebastian
    Pfarr, Nicole
    Mogler, Carolin
    Illert, Anna Lena
    PATHOLOGIE, 2024, 45 (03): : 180 - 189
  • [26] Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials
    Roberts, TG
    Goulart, BH
    Squitieri, L
    Stallings, SC
    Halpern, EF
    Chabner, BA
    Gazelle, GS
    Finkelstein, SN
    Clark, JW
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (17): : 2130 - 2140
  • [27] Risks and benefits of Twitter use by hematologists/oncologists in the era of digital medicine
    Attai, Deanna J.
    Anderson, Patricia F.
    Fisch, Michael J.
    Graham, David L.
    Katz, Matthew S.
    Kesselheim, Jennifer
    Markham, Merry Jennifer
    Pennell, Nathan A.
    Sedrak, Mina S.
    Thompson, Michael A.
    Utengen, Audun
    Dizon, Don S.
    SEMINARS IN HEMATOLOGY, 2017, 54 (04) : 198 - 204
  • [28] RETRACTION: Editorial: mRNA Vaccines and Immunotherapy in Oncology: A new Era for Personalized Medicine
    Parums, Dinah, V
    MEDICAL SCIENCE MONITOR, 2021, 27
  • [29] Personalized Medicine in Oncology; a Special Issue of the Journal of Personalized Medicine
    VanderWalde, Ari
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (07):
  • [30] Copenhagen prospective personalized oncology (CoPPO): Genomic profiling to select patients for phase 1 trials
    Tuxen, I. V.
    Yde, C. W.
    Mau-Sorensen, M.
    Santoni-Rugiu, E.
    Lassen, U.
    Nielsen, F. C.
    ANNALS OF ONCOLOGY, 2016, 27
12345